The primary care update series is a new premium content based service from bpacnz
Find out more
Register to use all the features of this website, including selecting clinical areas of interest and
“favourite” articles, taking part in quizzes and much more.
Hint: If you are a General Practitioner your username may be your MCNZ#
Interactive quizzes are based on material found in Best Practice Journal and Best Tests. Initially,
quizzes are posted out with journals and GPs are invited to submit their answers for CME credits.
to take part in quizzes.
Login to my bpac.
Don't have an account? Register to use all the features
of this website, including selecting clinical areas of interest, taking part in quizzes and much more.
Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) is a daily oral tablet that, when taken as prescribed, can...
Vaccination against human papillomavirus (HPV) infection provides safe and effective protection from genital warts, most cervical...
A new direct-acting antiviral (DAA) oral regimen for the treatment of hepatitis C, glecaprevir + pibrentasvir (Maviret) will be...
Hepatitis C infection occurs through exposure to infected blood or body fluids. The majority of newly acquired infections in New...
Patients should be assessed for cirrhosis via clinical examination, laboratory tests and an APRI score (or liver elastography...
Glecaprevir + pibrentasvir is taken once daily for eight weeks. Headache and fatigue are the most likely adverse effects. HCV...
Dr Tony Farrell is a general practitioner in Mount Maunganui and has a Fellowship in Addiction Medicine. He has a special interest...
Tenofovir disoproxil and entecavir are once daily oral antiviral medicines, recommended as first-line treatments for patients...
Since publication of our article on Zostavax vaccine in March, 2018, we have received feedback from several readers seeking clarification...
Two subsidised seasonal influenza vaccines, Influvac Tetra (for adults and children aged three years and over) and Fluarix Tetra...
Zostavax is a herpes zoster (shingles) vaccine that will become fully subsidised from 1 April, 2018 for people aged 65 years....
Three new oral medicine regimens for the treatment of hepatitis C, known as directly acting antivirals (DAAs), are fully subsidised...
Valaciclovir is an antiviral medicine which can be used for the treatment of Herpes simplex infections and herpes zoster. As of...
Copyright All Rights Reserved © bpacnz 2019
Follow us on facebook
View Guidelines »
Recertification programme »
Decision support for health professionals »
Info on the use of medicines in NZ »
South Island general practice support »
Practice acquisition and careers in health »